During the past decade, Mitoyo General Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
1995-04-01
Completed
130
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Mitoyo General Hospital
According to Clinical.Site data, the most researched conditions in "Mitoyo General Hospital" are
"Atrial Fibrillation" (1 trials), "Heart Failure" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Mitoyo General Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Mitoyo General Hospital
Most popular intervention types in "Mitoyo General Hospital" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mitoyo General Hospital
The vast majority of trials in "Mitoyo General Hospital" are
2 trials for "All" genders.
Clinical Trials Status at Mitoyo General Hospital
Currently, there are NaN active trials in "Mitoyo General Hospital".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Mitoyo General Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mitoyo General Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".